Exhibit 10.11
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), is entered into effective as of December 7, 2022 (the “Effective Date”), by and between Sensei Biotherapeutics, Inc. (the “Company”) and Edward van der Horst (the “Executive”). This Agreement amends, restates, and supersedes in its entirety the Employment Agreement between the Company and Executive dated October 16, 2021 (the “Prior Agreement”).
The Company desires to continue to employ Executive, now in the capacity of full-time Chief Scientific Officer pursuant to the terms of this Agreement and, in connection therewith, to compensate Executive for Executive’s personal services to the Company; and
Executive wishes to continue to be employed by the Company and provide personal services to the Company in return for certain compensation.
Accordingly, in consideration of the mutual promises and covenants contained herein, the parties agree to the following:
1
2
3
4
5
6
Subject to Section 6.3(b) below, the Company shall have the right to terminate Executive’s employment with the Company at any time for Cause by giving notice as described in Section 6.7 of this Agreement.
7
8
9
10
11
12
13
[SIGNATURES TO FOLLOW ON NEXT PAGE]
14
IN WITNESS WHEREOF, the parties have executed this Amended and Restated Employment Agreement on the day and year first written above.
SENSEI BIOTHERAPEUTICS, INC.
By:/s/ John Celebi
Name: John Celebi
Title: President and CEO
Executive:
/s/ Edward van der Horst
Edward van der Horst
Signature Page